Evaluation of the importance and relevance of dose intensity using epirubicin and cyclophosphamide in metastatic breast cancer: interim analysis of a prospective randomized trial.
Marschner
N
N
Medical University Hospital, Goettingen, Germany.
Kreienberg
R
R
Souchon
R
R
Räth
U
U
Eggeling
B
B
Voigtmann
R
R
Ruffert
K
K
Schütte
M
M
Ammon
A
A
Kesztyüs
T
T
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D015251:Epirubicin / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011446:Prospective Studies; D015996:Survival Rate
D015251:Epirubicin; D003520:Cyclophosphamide